FST-100 in the Treatment of Acute Adenoviral Conjunctivitis

Completed · Phase 2

Conditions studied: Acute Adenoviral Conjunctivitis

In brief

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.

Key facts

Study ID

NCT01470664

Run by

Shire

People needed

176

Starts

2012-12-17

Expected to finish

2014-05-23

Last updated by the study team

2021-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a clinical diagnosis of suspected acute adenoviral conjunctivitis in at least one eye.

You may not qualify if…

• Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle.

Where it is running

• Ora, Inc. — Andover, Massachusetts, United States
• Ora, Inc. — Noida, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.